登陆
当前位置: 首页 >> 检索结果

结果排序

文献格式

出版时间

出版类型

出版语言
共有 7489 条符合本次的查询结果， 用时 4.5418691 秒

2881. Allan Maleche: legal advocate for health justice and human rights.

作者: Aarathi Prasad.
来源: Lancet. 2024年403卷10434期1327页

2882. Biosafety regulations are not yet fit for purpose.

作者: Talha Burki.
来源: Lancet. 2024年403卷10434期1325-1326页

2883. Anti-LGBTQ+ laws in Africa harming health and research.

作者: Gilbert Nakweya.
来源: Lancet. 2024年403卷10434期1323-1324页

2884. Retraction and republication-Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials.

作者: The Lancet Editors.
来源: Lancet. 2024年403卷10434期1321页

2885. Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials.

作者: Qingyang Shi.;Yang Wang.;Qiukui Hao.;Per Olav Vandvik.;Gordon Guyatt.;Jing Li.;Zhe Chen.;Shishi Xu.;Yanjiao Shen.;Long Ge.;Feng Sun.;Ling Li.;Jiajie Yu.;Kailei Nong.;Xinyu Zou.;Siyi Zhu.;Cong Wang.;Shengzhao Zhang.;Zhi Qiao.;Zhongyu Jian.;Ya Li.;Xinyi Zhang.;Kerun Chen.;Furong Qu.;Yuan Wu.;Yazhou He.;Haoming Tian.;Sheyu Li.
来源: Lancet. 2024年403卷10434期e21-e31页
Pharmacotherapy provides an option for adults with overweight and obesity to reduce their bodyweight if lifestyle modifications fail. We summarised the latest evidence for the benefits and harms of weight-lowering drugs.

2886. Severe reactivation of seronegative occult hepatitis B after chemotherapy for lymphoma.

作者: Harrys A Torres.;Khalis Mustafayev.;Loretta J Nastoupil.;Samuel A Shelburne.
来源: Lancet. 2024年403卷10434期1372-1373页

2887. Department of Error.

来源: Lancet. 2024年403卷10434期1340页

2888. Department of Error.

来源: Lancet. 2024年403卷10434期1340页

2889. Department of Error.

来源: Lancet. 2024年403卷10434期1340页

2890. High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' reply.

作者: Leon Peto.;Buddha Basnyat.;Peter Horby.
来源: Lancet. 2024年403卷10434期1339-1340页

2891. High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.

作者: Sangeeta Bhusal.;Sudeep Adhikari.
来源: Lancet. 2024年403卷10434期1339页

2892. High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.

作者: Teluguakula Narasaraju.;Yazhini Ravi.;Colleen B Jonsson.;Vincent T K Chow.
来源: Lancet. 2024年403卷10434期1338-1339页

2893. High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.

作者: Nin-Chieh Hsu.;Yasuharu Tokuda.
来源: Lancet. 2024年403卷10434期1338页

2894. High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.

作者: Natalie McEvoy.;Jessica Lowry.;Aidan O'Dowd.;Gerard F Curley.;Fidelma Fitzpatrick.
来源: Lancet. 2024年403卷10434期1337页

2895. High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.

作者: Zia Hashim.;Alok Nath.;Naresh Kumar Tripathy.
来源: Lancet. 2024年403卷10434期1337-1338页

2896. Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan.

作者: Arne Søraas.;Sonja H Brunvoll.;Anders B Nygaard.;John Arne Dahl.;Giske Ursin.
来源: Lancet. 2024年403卷10434期1336页

2897. Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan - Authors' reply.

作者: Xiaoying Gu.;Lixue Huang.;Hui Zhang.;Bin Cao.
来源: Lancet. 2024年403卷10434期1336-1337页

2898. WHO-Lancet Global Series on health and the arts.

作者: Stephen Clift.;Arne Bathke.;Helena Daffern.;Christina Davies.;Katarzyna Grebosz-Haring.;Mette Kaasgaard.;J Matt McCrary.;George Musgrave.;Leonhard Thun-Hohenstein.
来源: Lancet. 2024年403卷10434期1335页

2899. The combination of systemic corticosteroids and inhaled adrenaline for bronchiolitis.

作者: Ben Gelbart.;Frank Shann.
来源: Lancet. 2024年403卷10434期1335页

2900. WHO should embrace tobacco harm reduction to save lives.

作者: Derek Yach.
来源: Lancet. 2024年403卷10434期1334-1335页
共有 7489 条符合本次的查询结果， 用时 4.5418691 秒